Study confirms close link between immune system and adult neurogenesis. News Medical, Published on August 19, 2014.
these findings would stimulate a new area of research into immune therapies to target neurological diseases
Saturday, August 23, 2014
More patients help drug companies pass valley of death - Indianapolis Business Journal
More patients help drug companies pass valley of death - Indianapolis Business Journal
But patient groups—especially those formed around rare and untreatable diseases—are indeed playing a crucial role in getting experimental drugs across the proverbial “valley of death”—where none of those deep-pocketed players want to put their money.
But patient groups—especially those formed around rare and untreatable diseases—are indeed playing a crucial role in getting experimental drugs across the proverbial “valley of death”—where none of those deep-pocketed players want to put their money.
Intellect Neurosciences, Inc. Issues Letter to Shareholders - GlobeNewswire press release
Intellect Neurosciences, Inc. Issues Letter to Shareholders - GlobeNewswire press release
Shire is developing OX1 as a treatment for Friedreich's Ataxia and possibly other diseases for which OX1 may qualify for orphan drug designation.
Shire is developing OX1 as a treatment for Friedreich's Ataxia and possibly other diseases for which OX1 may qualify for orphan drug designation.
Grant Alert: Hematopoietic Stem Cell-Based Therapy For Friedrich Ataxia (University Of California San Diego, La Jolla, United States)
Grant Alert: Hematopoietic Stem Cell-Based Therapy For Friedrich Ataxia (University Of California San Diego, La Jolla, United States). Project Leader: CHERQUI, STEPHANIE
The role of iron in neurodegenerative disorders: insights and opportunities with synchrotron light
The role of iron in neurodegenerative disorders: insights and opportunities with synchrotron light. Collingwood Joanna Frances, Davidson Mark Rogers, Front. Pharmacol., 19 August 2014 | doi: 10.3389/fphar.2014.00191
FULL TEXT PDF
FULL TEXT PDF
Subscribe to:
Posts (Atom)